Sionna Therapeutics (NASDAQ:SION) Shares Down 7.5% - What's Next?
Sionna Therapeutics (NASDAQ:SION) Stock Price Down 7.5% - Here's Why...
MarketBeat·22h ago
More News
Sionna Therapeutics, Inc. (NASDAQ:SION) Receives Average Recommendation of "Moderate Buy" from Analysts
Shares of Sionna Therapeutics, Inc. (NASDAQ:SION - Get Free Report) have been given a consensus recommendation of "Moderate Buy" by the nine ratings firms that are presently covering the stock...
MarketBeat·2d ago
A Sionna Therapeutics (SION) Insider Sold 33,000 Shares for $1.5 Million
Key Points33,356 shares sold for a transaction value of $1,486,009.80 on Dec. 24, 2025...
Nasdaq News: Markets·4d ago
Sionna Therapeutics (NASDAQ:SION) Director Peter Thompson Sells 33,356 Shares
Sionna Therapeutics, Inc. (NASDAQ:SION - Get Free Report) Director Peter Thompson sold 33,356 shares of the firm's stock in a transaction dated Wednesday, December 24th. The shares were sold at an...
MarketBeat·8d ago
Insider Selling: Sionna Therapeutics (NASDAQ:SION) Director Sells 33,356 Shares of Stock
Sionna Therapeutics, Inc. (NASDAQ:SION - Get Free Report) Director Peter Thompson sold 33,356 shares of the firm's stock in a transaction dated Wednesday, December 24th. The stock was sold at an...
MarketBeat·9d ago
Sionna Therapeutics (NASDAQ:SION) Sets New 12-Month High - What's Next?
Sionna Therapeutics (NASDAQ:SION) Sets New 12-Month High - Still a Buy...
MarketBeat·9d ago
FY2025 Earnings Estimate for SION Issued By Lifesci Capital
Sionna Therapeutics, Inc. (NASDAQ:SION - Free Report) - Lifesci Capital issued their FY2025 earnings estimates for Sionna Therapeutics in a research note issued on Tuesday, December 23rd. Lifesci...
MarketBeat·13d ago
Goldman's Small-Cap Biotech Universe: The 2026 Catalyst Playbook For Investors
Goldman's Small-Cap Biotech Universe: The 2026 Catalyst Playbook For Investors There are just nine days left in the year, and this year has flown by. We've delivered readers a steady stream of 2026...
Zero Hedge·15d ago
Sionna Therapeutics (NASDAQ:SION) Coverage Initiated by Analysts at Lifesci Capital
Lifesci Capital began coverage on shares of Sionna Therapeutics in a research report on Tuesday. They issued an "outperform" rating and a $60.00 price target for the company...
MarketBeat·15d ago
Sionna Therapeutics (NASDAQ:SION) Director Orbimed Advisors Llc Sells 875 Shares
Sionna Therapeutics, Inc. (NASDAQ:SION - Get Free Report) Director Orbimed Advisors Llc sold 875 shares of Sionna Therapeutics stock in a transaction that occurred on Friday, December 19th. The...